Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 6/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14735535 | 0.88 | MAPT (0.41) | KDM4EKMT2AL3MBTL1FAAHCNR1 | |
| SCHEMBL7610436 | 0.83 | EGLN2 (0.38) | KMT2AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL1509110 | 0.83 | EGLN2 (0.52) | KDM4EKMT2AL3MBTL1FAAHCNR1 | |
| SCHEMBL7605070 | 0.83 | KDM4E (0.47) | KDM4EFAAHALDH1A1MAPT | |
| SCHEMBL7614162 | 0.83 | KDM4E (0.47) | KDM4EFAAHALDH1A1MAPT | |
| SCHEMBL7614301 | 0.83 | KDM4E (0.47) | KDM4EFAAHALDH1A1MAPT | |
| SCHEMBL7612233 | 0.83 | KDM4E (0.47) | KDM4EFAAHALDH1A1MAPT | |
| SCHEMBL7610580 | 0.83 | KDM4E (0.47) | KDM4EFAAHALDH1A1MAPT | |
| SCHEMBL7609545 | 0.83 | KDM4E (0.47) | KDM4EFAAHALDH1A1MAPT | |
| SCHEMBL7605129 | 0.83 | KDM4E (0.47) | KDM4EFAAHALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1463823-B1 | METHODS OF INCREASING ENDOGENOUS ERYTHROPOIETIN (EPO) | FIBROGEN INC (US) | 2013-03-06 | — | — | EP | claimed |